Advanced Proteome Therapeutics Corporation
APCH.V
TSX
| 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -2.04M | -1.03M | -125.90K | 759.60K | 986.60K |
| Total Depreciation and Amortization | 3.70K | 4.80K | 4.80K | 4.80K | 4.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.04M | -75.50K | -956.10K | -1.76M | -1.88M |
| Change in Net Operating Assets | 62.60K | 291.30K | 281.60K | 301.20K | 276.80K |
| Cash from Operations | -934.90K | -811.30K | -795.90K | -693.60K | -614.20K |
| Capital Expenditure | -700.00 | -700.00 | 0.00 | -13.80K | -15.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -114.40K | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 214.80K | -35.10K | -- | -- | -48.10K |
| Cash from Investing | 99.70K | -35.80K | 0.00 | -13.80K | -63.70K |
| Total Debt Issued | -182.10K | -24.10K | 0.00 | 0.00 | 292.10K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 334.80K | 334.80K | 429.40K | 429.40K | 183.00K |
| Repurchase of Common Stock | -40.40K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 112.30K | 310.70K | 429.40K | 429.40K | 475.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -722.90K | -536.30K | -366.40K | -277.90K | -202.70K |